Cargando…
Host defense peptides for treatment of colorectal carcinoma – a comparative in vitro and in vivo analysis
Host defense peptides (HDP) constitute effector molecules of the innate immune system. Besides acting against microbia and fungi, they exhibit broad and selective oncolytic activity. The underlying mechanism is at least partially attributable to elevated surface-exposed levels of phosphatidylserine...
Autores principales: | Maletzki, Claudia, Klier, Ulrike, Marinkovic, Samuel, Klar, Ernst, Andrä, Jörg, Linnebacher, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147338/ https://www.ncbi.nlm.nih.gov/pubmed/24962950 |
Ejemplares similares
-
Bacterial immunotherapy of gastrointestinal tumors
por: Linnebacher, Michael, et al.
Publicado: (2011) -
Cryopreservation of human colorectal carcinomas prior to xenografting
por: Linnebacher, Michael, et al.
Publicado: (2010) -
Ex-vivo Clonally Expanded B Lymphocytes Infiltrating Colorectal Carcinoma Are of Mature Immunophenotype and Produce Functional IgG
por: Maletzki, Claudia, et al.
Publicado: (2012) -
Targeting Immune-Related Molecules in Cancer Therapy: A Comprehensive In Vitro Analysis on Patient-Derived Tumor Models
por: Maletzki, Claudia, et al.
Publicado: (2019) -
Murine Endogenous Retroviruses Are Detectable in Patient-Derived Xenografts but Not in Patient-Individual Cell Lines of Human Colorectal Cancer
por: Bock, Stephanie, et al.
Publicado: (2018)